Search

Your search keyword '"Rafia, Rachid"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Rafia, Rachid" Remove constraint Author: "Rafia, Rachid"
38 results on '"Rafia, Rachid"'

Search Results

1. Guiding the choice of analytic approach for economic evaluations of oncology treatments

3. Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast Cancer

13. Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast Cancer

14. Evaluating the cost-effectiveness of the addition of rituximab to chemotherapy in the first-line treatment of Follicular Lymphoma patients in the UK

15. Does the generic cancer outcome measure EORTC QLQ-C30 work in Myelofibrosis? (ISPOR 20th Annual International Meeting 16-20 May 2015)

16. Exploratory psychometric analysis of the EQ-5D in a Myelofibrosis population (ISPOR 20th Annual International Meeting 16-20 May 2015)

24. An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence

25. The Sheffield alcohol policy model - a mathematical description

26. Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi – a systematic review and economic evaluation

27. An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence

33. Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia: an evidence review group perspective of a NICE single technology appraisal

34. Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia: an evidence review group perspective of a NICE single technology appraisal

35. Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia: an evidence review group perspective of a NICE single technology appraisal

36. Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia: an evidence review group perspective of a NICE single technology appraisal

37. The Sheffield Alcohol Policy Model - A Mathematical Description.

38. Healthcare costs and productivity losses directly attributable to ankylosing spondylitis.

Catalog

Books, media, physical & digital resources